Free Trial

Nexalin Technology (NXL) Competitors

$0.72
-0.02 (-2.70%)
(As of 06/7/2024 ET)

NXL vs. QTI, STRR, GIA, NUWE, HSDT, NDRA, TIVC, VRAYQ, VIVE, and MDT

Should you be buying Nexalin Technology stock or one of its competitors? The main competitors of Nexalin Technology include QT Imaging (QTI), Star Equity (STRR), GigCapital5 (GIA), Nuwellis (NUWE), Helius Medical Technologies (HSDT), ENDRA Life Sciences (NDRA), Tivic Health Systems (TIVC), ViewRay (VRAYQ), Viveve Medical (VIVE), and Medtronic (MDT). These companies are all part of the "electromedical equipment" industry.

Nexalin Technology vs.

Nexalin Technology (NASDAQ:NXL) and QT Imaging (NASDAQ:QTI) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, community ranking, media sentiment, valuation, profitability and analyst recommendations.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nexalin Technology
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
QT Imaging
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

QT Imaging has lower revenue, but higher earnings than Nexalin Technology.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nexalin Technology$110K48.70-$4.65M-$0.66-1.09
QT ImagingN/AN/A-$4.03MN/AN/A

Nexalin Technology and QT Imaging both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Nexalin TechnologyN/AN/A
QT ImagingN/AN/A

0.7% of Nexalin Technology shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 27.7% of Nexalin Technology shares are owned by company insiders. Comparatively, 75.4% of QT Imaging shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

QT Imaging has a net margin of 0.00% compared to Nexalin Technology's net margin of -3,088.12%. QT Imaging's return on equity of 0.00% beat Nexalin Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Nexalin Technology-3,088.12% -154.84% -122.94%
QT Imaging N/A N/A -19.75%

Nexalin Technology has a beta of 5.13, suggesting that its stock price is 413% more volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.13, suggesting that its stock price is 113% less volatile than the S&P 500.

In the previous week, Nexalin Technology had 3 more articles in the media than QT Imaging. MarketBeat recorded 4 mentions for Nexalin Technology and 1 mentions for QT Imaging. QT Imaging's average media sentiment score of 1.15 beat Nexalin Technology's score of 0.00 indicating that QT Imaging is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nexalin Technology
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
QT Imaging
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

QT Imaging beats Nexalin Technology on 7 of the 10 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NXL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NXL vs. The Competition

MetricNexalin TechnologyElectromedical equipment IndustryBusiness SectorNASDAQ Exchange
Market Cap$5.35M$3.43B$6.76B$8.18B
Dividend YieldN/A1.66%2.72%4.05%
P/E Ratio-1.097.8031.7115.79
Price / Sales48.7072.461,296.9372.49
Price / CashN/A69.0723.5030.66
Price / Book1.673.824.684.32
Net Income-$4.65M$86.13M$121.61M$216.21M
7 Day Performance2.86%-2.89%-0.84%-1.44%
1 Month Performance-37.93%-4.53%-1.86%-0.97%
1 Year Performance-15.83%-7.79%1.85%4.10%

Nexalin Technology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QTI
QT Imaging
0 of 5 stars
$0.72
+0.1%
N/AN/A$15.53MN/A0.00N/APositive News
STRR
Star Equity
2.9993 of 5 stars
$0.83
-3.5%
N/A-24.3%$13.16M$45.78M0.64171Gap Up
GIA
GigCapital5
0 of 5 stars
$0.72
-7.7%
N/A-93.8%$6.27MN/A0.002,021Gap Up
High Trading Volume
NUWE
Nuwellis
0 of 5 stars
$0.24
-7.8%
N/A-92.7%$4.36M$8.86M-0.0359Gap Down
HSDT
Helius Medical Technologies
0.8696 of 5 stars
$1.40
-0.5%
$24.00
+1,611.0%
-84.5%$3.55M$640,000.00-0.1126Positive News
Gap Up
NDRA
ENDRA Life Sciences
1.4433 of 5 stars
$0.24
-9.9%
N/A-93.5%$2.68MN/A-0.1921Analyst Forecast
Gap Down
TIVC
Tivic Health Systems
0 of 5 stars
$0.40
-2.2%
N/A-95.8%$2.49M$1.18M0.009
VRAYQ
ViewRay
0 of 5 stars
$0.00
+∞
N/AN/A$18,000.00$102.21M0.00295Gap Up
VIVE
Viveve Medical
0 of 5 stars
$0.00
flat
N/A-40.0%$3,000.00$6.43M0.0047
MDT
Medtronic
4.7924 of 5 stars
$81.67
+0.4%
$93.00
+13.9%
+1.2%$108.44B$32.36B29.7095,000Analyst Forecast

Related Companies and Tools

This page (NASDAQ:NXL) was last updated on 6/9/2024 by MarketBeat.com Staff

From Our Partners